Thermo Fisher Scientific

Thermo Fisher Scientific

Yahoo Finance • yesterday

Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?

Avantor, Inc. AVTR is showing clearer signs that its Revival program is improving execution. VWR returned to growth sooner than expected, Bioscience & Medtech Products orders strengthened and management raised its 2026 outlook. The recove... Full story

Yahoo Finance • 2 days ago

Top Research Reports for Amgen, Thermo Fisher & Pepsi

Monday, August 24, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Thermo Fisher Scientific Inc.... Full story

Yahoo Finance • 3 days ago

Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?

Turnarounds in the healthcare sector do not all look the same. Some companies recover because management executes better, launches stronger products, and improves operations, while others do so because the industries they serve begin impro... Full story

Yahoo Finance • 3 days ago

Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?

Healthcare investors are often faced with a choice between companies that generate steady growth across diversified businesses and those positioned to benefit from improving industry conditions. Abbott Laboratories (NYSE:ABT) and Thermo Fi... Full story

Yahoo Finance • 3 days ago

Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?

Healthcare investors looking for long-term growth don't always have to choose between fast-growing companies and defensive businesses. Sometimes the more interesting decision is between two high-quality companies that are growing for entir... Full story

Yahoo Finance • 3 days ago

Thermo Fisher vs. Intuitive Surgical: Which Premium Healthcare Stock Deserves its Valuation?

Premium healthcare stocks often trade at elevated valuations for very different reasons. Thermo Fisher's (NYSE:TMO) investment case increasingly depends on whether the life sciences industry is emerging from its post-pandemic slowdown, whi... Full story

Yahoo Finance • 3 days ago

The six stocks both hedge funds and mutual funds love - Goldman

[Financial and Economy] FREDERICA ABAN Goldman Sachs has identified six stocks that rank among the favorite holdings of both hedge funds and mutual funds heading into the third quarter. Boeing (BA [https://seekingalpha.com/symbol/BA]), C... Full story

Yahoo Finance • 4 days ago

Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Thermo Fisher Scientific (TMO) is drawing investor attention after completing Olink Explore HT proteomic analysis on about 5,500 s... Full story

Yahoo Finance • 11 days ago

3 Profitable Stocks We’re Skeptical Of

3 Profitable Stocks We're Skeptical Of Even if a company is profitable, it doesn't always mean it's a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.... Full story

Yahoo Finance • 15 days ago

Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific

Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035"... Full story

Yahoo Finance • 16 days ago

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 1%.In corporate news, Eli L... Full story

Yahoo Finance • 21 days ago

[Latest] Global Deep Eutectic Solvents Market Size/Share Worth USD 735.89 Million by 2034 at a 15.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Deep Eutectic Solvents Market size & share revenue was valued at approximately USD 1... Full story

Yahoo Finance • 23 days ago

3 Cash-Producing Stocks We Think Twice About

3 Cash-Producing Stocks We Think Twice About Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportun... Full story

Yahoo Finance • 26 days ago

Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings?

Thermo Fisher Scientific Inc. (NYSE:TMO) recently announced strong fiscal Q2 2026 results, with revenue growing 10% to $11.99 billion, GAAP diluted EPS rising 9% to $4.68, and adjusted EPS growing 13% to $6.03. The results prompted several... Full story

Yahoo Finance • 28 days ago

Ontex appoints Stéphane Re as Group CFO

Ontex Aalst, Belgium, July 30, 2026 – Ontex Group NV, a leading international developer and producer of personal care products,  announces the appointment of Stéphane Re as Group CFO and member of the Executive Management Committee, effec... Full story

Yahoo Finance • 28 days ago

Ontex benoemt Stéphane Re tot Group CFO

Aalst, België, 30 juli 2026 – Ontex Group NV, een toonaangevende internationale ontwikkelaar en producent van persoonlijke verzorgingsproducten, kondigt de benoeming aan van Stéphane Re tot Group CFO en lid van het Uitvoerend Comité, met i... Full story

Yahoo Finance • last month

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

Investors choosing between Simplify Health Care ETF (NYSEMKT:PINK) and State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) may weigh the SPDR fund's significantly lower costs against the Simplify fund's active management and char... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus

Wall Street's major averages aimed to go higher on Friday but closed mixed as oil prices declined. The benchmark S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_... Full story

Yahoo Finance • last month

TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves

TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 10.5% year on year to $11.99... Full story

Yahoo Finance • last month

Thermo Fisher (TMO) Lands ImmuPharma Kapiglucagon Diabetes Manufacturing Role

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Thermo Fisher Scientific (NYSE:TMO) has been selected by ImmuPharm... Full story